Fabien Praz

Showing 1-13 of 13 articles

Transcatheter tricuspid valve treatment: does annular reduction make a difference?

Praz F, Brugger N

February 5, 2021 | 10.4244/EIJV16I15A219

Transcatheter treatment of multivalvular heart disease

Winkel M, Brugger N, Hunziker L, Windecker S, Praz F

November 20, 2020 | 10.4244/EIJ-D-20-00244

Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores

Ueki Y, Bär S, Losdat S, Otsuka T, Zanchin C, Zanchin T, Gragnano F, Gargiulo G, Siontis G, Praz F, Lanz J, Hunziker L, Stortecky S, Pilgrim T, Heg D, Valgimigli M, Windecker S, Räber L

August 28, 2020 | 10.4244/EIJ-D-20-00052

Optimal fluoroscopic viewing angles of right-sided heart structures in patients with tricuspid regurgitation based on multislice computed tomography

Xiong T, Pighi M, Thériault-Lauzier P, Leipsic J, Spaziano M, Martucci G, Buithieu J, Mousavi N, Pilgrim T, Praz F, Windecker S, Chen M, Piazza N

November 15, 2019 | 10.4244/EIJ-D-19-00618

Interventions for stroke

Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale

Susuri N, Obeid S, Ulmi M, Siontis G, Wahl A, Windecker S, Nietlispach F, Meier B, Praz F

September 20, 2017 | 10.4244/EIJ-D-17-00061

Interventions for valvular disease

Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation

Franzone A, O’Sullivan C, Stortecky S, Heg D, Lanz J, Vollenbroich R, Praz F, Piccolo R, Asami M, Roost E, Räber L, Valgimigli M, Windecker S, Pilgrim T

April 7, 2017 | 10.4244/EIJ-D-16-00790

Interventions for valvular disease

Bilateral, reversible coronary obstruction during aortic valve-in-valve implantation of a repositionable valve system

Praz F, Moschovitis A, Stortecky S, Pilgrim T, Eberle B, Windecker S

October 20, 2016 | 10.4244/EIJV12I9A194

Interventions for valvular disease

Effect of resting heart rate on two-year clinical outcomes of high-risk patients with severe symptomatic aortic stenosis undergoing transcatheter aortic valve implantation

O’Sullivan C, Spitzer E, Heg D, Praz F, Stortecky S, Huber C, Carrel T, Pilgrim T, Windecker S

July 20, 2016 | 10.4244/EIJV12I4A83

Interventions for valvular disease

Transcatheter aortic valve implantation with the NVT Allegra transcatheter heart valve system: first-in-human experience with a novel self-expanding transcatheter heart valve

Wenaweser P, Stortecky S, Schütz T, Praz F, Gloekler S, Windecker S, Elsasser A

May 16, 2016 | 10.4244/EIJV12I1A13

A propensity score-matched comparison between Cardia and Amplatzer PFO closure devices - insights from the SOLUTION registry (Swiss percutaneOus patent foramen ovale cLosUre in recurrent clinical events prevenTION)

Puricel S, Arroyo D, Goy J-J, Praz F, Palhais N, Wahl A, Stauffer J-C, Togni M, Berger A, Meier B, Cook S

June 19, 2015 | 10.4244/EIJY14M05_05

Assessment of low-flow, low-gradient, severe aortic stenosis: an invasive evaluation is required for decision making

O’Sullivan C, Praz F, Stortecky S, Windecker S, Wenaweser P

September 27, 2014 | 10.4244/EIJV10SUA9

Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device

Bapat V, Buellesfeld L, Peterson MD, Hancock J, Reineke D, Buller C, Carrel T, Praz F, Rajani R, Fam N, Kim H, Redwood S, Young C, Munns C, Windecker S, Thomas M

September 27, 2014 | 10.4244/EIJV10SUA18

Cerebral protection devices for transcatheter aortic valve implantation: is better the enemy of good?

Praz F, Nietlispach F

September 15, 2013 | 10.4244/EIJV9SSA26

1

Latest news

State-of-the-Art on Coronary Physiology; a Mini Focus on Biostatistics; Post-TAVI Aortic Manipulation; Minimally Invasive Ventricular Reconstruction after MI

EBC 15th consensus document

Save the date: 19th April at 6pm (CET). Join us on Twitter for the 2nd edition

This Week's JAA's: Deep Learning Model to Detect AMI, Mortality After Bleeding vs MI in CAD Patients...

New update: EXAMINATION 10 years, BIONYX 2 years, SAFE A, MASH and more

(Thanks to the support of Biotronik)

Randomised Comparison between POT and KBT: PROPOT Trial

Yusuke Watanabe et al.

Similar long-term outcome of dissimilar drug-eluting stents: is it time to change the assessment?

Clemens von Birgelen et al.

Optimising Physiological Endpoints of Percutaneous Coronary Intervention

Valvular disease